CJC-1295 + Ipamorelin is a research-grade peptide combination that pairs CJC-1295 (a growth hormone-releasing hormone analogue) with Ipamorelin (a selective ghrelin receptor agonist) to achieve synergistic stimulation of growth hormone (GH) secretion.
This combination is studied in preclinical and in vitro research to explore pulsatile GH release, IGF-1 production, body composition modulation, recovery, and regenerative physiology. It allows researchers to investigate both hypothalamic and pituitary mechanisms regulating GH dynamics.
Nox Amino supplies materials that are intended exclusively for laboratory research and development use by qualified technical personnel. These materials are not intended for human ingestion, human or veterinary medical use, household use, cosmetic use, or self-directed experimentation. Materials are not labeled, sold, or represented as finished products for administration to humans or animals, and are not offered for the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals. Purchase, possession, and use may be restricted by law. Buyer represents that materials will be handled consistent with applicable safety practices, institutional policies, and all applicable federal, state, and local laws and regulations. Nothing on this website is dosing guidance, clinical advice, or instructions for use. Certificates of Analysis (COAs) describe analytical characterization for the specific catalog item and lot and do not expand or alter the intended scope of sale.
